How do you pay?

How to pay the least

Ask for the cash price

Papzimeos

Papzimeos is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Papzimeos’s cash price, and one or two other pharmacies too.
  2. Papzimeos’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand namePapzimeos
Authorized genericzopapogene imadenovec
Regular genericzopapogene imadenovec
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Papzimeos?
The original
–
–

Brand nameThe maker’s card

Papzimeos SUPPORT Copay Program

Savings card from Precigen

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a treatment

Sign up on papzimeos.com 

Or call 1-866-827-8180.

In the maker’s words

“Eligible patients may pay as little as $0 out of pocket for PAPZIMEOS…”

From the maker’s offer on papzimeos.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Papzimeos itself, from the same company, sold without the brand name, and usually for less. For now Papzimeos is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Papzimeos is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

PAPZIMEOS™ is a non-replicating adenoviral vector-based immunotherapy indicated for the treatment of adults with recurrent respiratory papillomatosis.

Source: the FDA label for Papzimeos (Precigen, Inc.), August 12, 2025. Full label on DailyMed 

Good to know